Acid, Hyaluronic, Intraarticular
Main Filters
Acid, Hyaluronic, Intraarticular
9902392 Canada Inc | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
024 | 0 | - |
ACRE PHARMA LIMITED | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
N/A | 0 | - | ||
N/A | 0 | - | ||
N/A | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - |
ALLY MEDICAL SUPPLIES LTD | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
NA | 0 | - | ||
None | 0 | - | ||
None | 0 | - | ||
None | 0 | - | ||
None | 0 | - |
Anika Therapeutics, Inc. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
630-254 | 0 | - | ||
690-016 | 0 | - |
FCL HEALTH SOLUTIONS LTD | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
HYLAN GF-20 | 0 | - | ||
HYLAN GF-20 | 0 | - | ||
NA | 0 | - | ||
None | 0 | - | ||
None | 0 | - |
FERRING PHARMACEUTICALS INC. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
4100 | 0 | - |
FIDIA FARMACEUTICI SPA | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
89122-0496-01 | 0 | - | ||
89122-0496-63 | 0 | - | ||
89122-0724-12 | 0 | - | ||
89122-0724-20 | 0 | - | ||
89122-0879-01 | 0 | - | ||
89122-4966-30 | 0 | - | ||
FID10000317 | 0 | - | ||
FID185704 | 0 | - | ||
FID185704 | 0 | - |
GENZYME CORPORATION | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
002401 | 0 | - |
IBSA FARMACEUTICI ITALIA SRL | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
GS3111 | 0 | - |
PAVAN TRADING LTD | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
N/A | 0 | - | ||
None | 0 | - | ||
None | 0 | - | ||
None | 0 | - | ||
None | 0 | - | ||
None | 0 | - |
PHARMACEUTICAL HEALTH LIMITED | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
5 Count | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - |
PROPHARMA-UK LTD | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
NA | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - |
SEIKAGAKU CORPORATION | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
7156-4444 | 0 | - | ||
7156-5555 | 0 | - |
79 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
SUPARTZ® sodium hyaluronate
SEIKAGAKU CORPORATION
SUPARTZ (P980044) is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. SUPARTZ is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) (620 000-1 170 000 daltons). HA, which is extracted from rooster combs, is a polysaccharide containing repeating disaccharide units of glucuronic acid and N-acetylglucosamine. HA is a common constituent of the extracellular matrix of connective tissues. SUPARTZ is supplied sterile in single-use, pre-filled, disposable plastic syringes, each containing 25 mg of HA dissolved in a Phosphate Buffered Saline (PBS) solution (2.5 mL of 1.0% solution).
0
-
SUPARTZ FX sodium hyaluronate
SEIKAGAKU CORPORATION
SUPARTZ FX (P980044) is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. SUPARTZ FX is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) (620 000-1 170 000 daltons). HA, which is extracted from chicken combs, is a polysaccharide containing repeating disaccharide units of glucuronic acid and N-acetylglucosamine. HA is a common constituent of the extracellular matrix of connective tissues. SUPARTZ FX is supplied sterile in single-use, pre-filled, disposable plastic syringes, each containing 25 mg of HA dissolved in a Phosphate Buffered Saline (PBS) solution (2.5 mL of 1.0% solution).
0
-
Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe
FIDIA FARMACEUTICI SPA
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen).
0
-
Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe
FIDIA FARMACEUTICI SPA
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen).
0
-
TriLURON
FIDIA FARMACEUTICI SPA
TriLURON (sodium hyaluronate) 1 prefilled syringe - 2 mL, 20mg per 2 mL - Professional Sample - Not for Sale
0
-
TriLURON
FIDIA FARMACEUTICI SPA
TriLURON (sodium hyaluronate) 1 prefilled syringe - 2 mL, 20mg per 2 mL
0
-
Hyalgan® Sodium Hylauronate Pre-filled Syringe - 2mL
FIDIA FARMACEUTICI SPA
Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL syringe is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days.
0
-
Hyalgan® Sodium Hyaluronate 2mL Vial
FIDIA FARMACEUTICI SPA
Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days.
0
-
Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe
FIDIA FARMACEUTICI SPA
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals.
0
-
Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe
FIDIA FARMACEUTICI SPA
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals.
0
-
Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe, 1 pack
FIDIA FARMACEUTICI SPA
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking. The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals. The product is packaged in a one syringe pack.
0
-
GELSYN-3
IBSA FARMACEUTICI ITALIA SRL
INTRA-ARTICULAR HYALURONIC ACID. 1 PRE-FILLED SYRINGE CONTAINING 16.8 mg / 2 mL HYALURONIC ACID SODIUM SALT
0
-
Euflexxa
PAVAN TRADING LTD
Euflexxa is injected into the knee to relieve the pain of osteoarthritis.
0
-
Supartz
PAVAN TRADING LTD
Supartz is injected into the knee to relieve the pain of osteoarthritis.
0
-
Monovisc
PAVAN TRADING LTD
Monovisc is injected into the knee to relieve the pain of osteoarthritis.
0
-
Synvisc One (Synvisc Three)
PAVAN TRADING LTD
Synvisc is injected into the knee to alleviate the pain of osteoarthritis.
- 1
- 2